EMA committee recommends Nyxoid naloxone nasal spray for opioid overdose without a prescription
In October 2026 the EMA's human medicines committee recommended making Nyxoid (naloxone) available without a prescription.
In October 2026 the EMA's human medicines committee recommended making Nyxoid (naloxone) available without a prescription.
On 16 October 2026 the EMA's human medicines committee recommended authorising Foundayo (orforglipron) in the EU.
On 15 October 2026 the EMA's human medicines committee adopted a positive opinion extending the indication of AstraZeneca's H5N1 pandemic vaccine.
The UK medicines regulator and West Midlands Police seized more than 12,000 fake weight-loss pens in a raid on 14 October 2026.
On 7 October 2026 WHO released its first global guidelines on caring for children and adolescents with obesity.
In 1538 the Swiss physician Paracelsus wrote: all things are poison, and nothing is without poison; the dosage alone makes it so a thing is not a poison.
Researchers at the UK medicines regulator, with the GSK Vaccines Institute for Global Health, tested a Strep A vaccine given through the nose or under the tongue.
On 8 October 2026 WHO and partners launched a global roadmap on hypertensive disorders of pregnancy.
Australia's Therapeutic Goods Administration has approved a once-daily oral tablet form of semaglutide, sold as Wegovy.
On 15 October 2026 the EMA recommended authorising Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma.
Nothing more to show